{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:12:14Z","timestamp":1789056734253,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12916-015-0531-0","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T16:51:03Z","timestamp":1449679863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency"],"prefix":"10.1186","volume":"13","author":[{"given":"J. Kevin","family":"Baird","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,14]]},"reference":[{"key":"531_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1179\/2047773215Y.0000000016","volume":"109","author":"JK Baird","year":"2015","unstructured":"Baird JK. Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria. Pathog Glob Health. 2015;109:93\u2013106.","journal-title":"Pathog Glob Health"},{"key":"531_CR2","doi-asserted-by":"publisher","first-page":"e0003602","DOI":"10.1371\/journal.pntd.0003602","volume":"9","author":"AW Satyagraha","year":"2015","unstructured":"Satyagraha AW, Sadhewa A, Baramuli V, Elvira R, Ridenour C, Elyazar I, et al. G6PD deficiency at Sumba in eastern Indonesia is prevalent, diverse, and severe: implications for primaquine therapy against relapsing vivax malaria. PLoS Negl Trop Dis. 2015;9:e0003602.","journal-title":"PLoS Negl Trop Dis"},{"key":"531_CR3","doi-asserted-by":"crossref","unstructured":"Howes RE, Piel FB, Patil AP, Gething PW, Dewi M, Hogg MM, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9:e1001339.","DOI":"10.1371\/journal.pmed.1001339"},{"issue":"6 Suppl","key":"531_CR4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.2007.77.79","volume":"77","author":"RN Price","year":"2007","unstructured":"Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007;77(6 Suppl):79\u201387.","journal-title":"Am J Trop Med Hyg"},{"key":"531_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1128\/CMR.00074-12","volume":"26","author":"JK Baird","year":"2013","unstructured":"Baird JK. Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev. 2013;26:36\u201357.","journal-title":"Clin Microbiol Rev"},{"key":"531_CR6","volume-title":"Chemotherapy of malaria","author":"LJ Bruce-Chwatt","year":"1981","unstructured":"Bruce-Chwatt LJ, Black RH, Canfield CJ, Clyde DF, Peters W, Wernsdorfer WH. Chemotherapy of malaria. 2nd ed. Geneva: World Health Organization; 1981.","edition":"2"},{"key":"531_CR7","volume-title":"Safety of 8-aminoquinoline antimalarial medicines","author":"J Recht","year":"2014","unstructured":"Recht J, Ashley E, White N. Safety of 8-aminoquinoline antimalarial medicines. Geneva: World Health Organization; 2014."},{"key":"531_CR8","volume-title":"Global technical strategy for malaria 2016\u20132030","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Global technical strategy for malaria 2016\u20132030. Geneva: World Health Organization; 2015."},{"key":"531_CR9","volume-title":"Control and elimination of Plasmodium vivax malaria. A technical brief","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Control and elimination of Plasmodium vivax malaria. A technical brief. Geneva: World Health Organization; 2015."},{"key":"531_CR10","volume-title":"Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria. WHO Evidence Review Group meeting report, 8\u20139 October 2014, WHO\/UNAIDS Building, Geneva, Switzerland","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria. WHO Evidence Review Group meeting report, 8\u20139 October 2014, WHO\/UNAIDS Building, Geneva, Switzerland. Geneva: World Health Organization; 2015."},{"key":"531_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1475-2875-13-144","volume":"13","author":"KE Battle","year":"2014","unstructured":"Battle KE, Karhunen MS, Bhatt S, Gething PW, Howes RE, Golding N, et al. Geographical variation in Plasmodium vivax relapse. Malaria J. 2014;13:144.","journal-title":"Malaria J"},{"key":"531_CR12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4269\/ajtmh.1949.s1-29.203","volume":"29","author":"E Hill","year":"1949","unstructured":"Hill E, Amatuzio DS. Southwest Pacific vivax malaria: clinical features and observations concerning duration of clinical activity. Am J Trop Med Hyg. 1949;29:203\u201314.","journal-title":"Am J Trop Med Hyg"},{"key":"531_CR13","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1128\/AAC.01879-12","volume":"57","author":"I Sutanto","year":"2013","unstructured":"Sutanto I, Tjahjono B, Basri H, Taylor WR, Putri FA, Meilia RA, et al. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia. Antimicrob Agents Chemother. 2013;57:1128\u201335.","journal-title":"Antimicrob Agents Chemother"},{"key":"531_CR14","doi-asserted-by":"crossref","unstructured":"White MT, Karl S, Battle KE, Hay SI, Mueller I, Ghani AC. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission. Elife. 2014; 3. doi: 10.7554\/eLife.04692","DOI":"10.7554\/eLife.04692"},{"key":"531_CR15","doi-asserted-by":"publisher","first-page":"e1979","DOI":"10.1371\/journal.pntd.0001979","volume":"7","author":"M Roy","year":"2013","unstructured":"Roy M, Bouma MJ, Ionides EL, Dhiman RC, Pascual M. The potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW India. PLoS Negl Trop Dis. 2013;7:e1979.","journal-title":"PLoS Negl Trop Dis"},{"key":"531_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/1475-2875-13-385","volume":"13","author":"RJ Maude","year":"2014","unstructured":"Maude RJ, Nguon C, Ly P, Bunkea T, Ngor P, de la Torre SE C, et al. Spatial and temporal epidemiology of clinical malaria in Cambodia 2004-2013. Malaria J. 2014;13:385.","journal-title":"Malaria J"},{"key":"531_CR17","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(13)62568-4","volume":"383","author":"A Llanos-Cuentas","year":"2014","unstructured":"Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, et al. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet. 2014;383:1049\u201358.","journal-title":"Lancet"},{"key":"531_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/1475-2875-12-391","volume":"12","author":"GJ Domingo","year":"2013","unstructured":"Domingo GJ, Satyagraha AW, Anvikar A, Baird JK, Bancone G, Bansil P, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malaria J. 2013;12:391.","journal-title":"Malaria J"},{"key":"531_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4269\/ajtmh.14-0298","volume":"92","author":"L Osorio","year":"2015","unstructured":"Osorio L, Carter N, Arthur P, Bancone G, Gopalan S, Gupta SK, et al. Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects. Am J Trop Med Hyg. 2015;92:22\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"531_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4269\/ajtmh.2010.09-0416","volume":"82","author":"KE Tinley","year":"2010","unstructured":"Tinley KE, Loughlin AM, Jepson A, Barnett ED. Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg. 2010;82:210\u20134.","journal-title":"Am J Trop Med Hyg"},{"key":"531_CR21","doi-asserted-by":"publisher","first-page":"854","DOI":"10.4269\/ajtmh.14-0194","volume":"91","author":"N LaRue","year":"2014","unstructured":"LaRue N, Kahn M, Murray M, Leader BT, Bansil P, McGray S, et al. Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg. 2014;91:854\u201361.","journal-title":"Am J Trop Med Hyg"},{"key":"531_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.trsl.2014.09.009","volume":"165","author":"JK Baird","year":"2015","unstructured":"Baird JK, Dewi M, Subekti D, Elyazar I, Satyagraha AW. Non-inferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells. Transl Res. 2015;165:677\u201388.","journal-title":"Transl Res"},{"key":"531_CR23","doi-asserted-by":"publisher","first-page":"e0125796","DOI":"10.1371\/journal.pone.0125796","volume":"10","author":"D Adu-Gyasi","year":"2015","unstructured":"Adu-Gyasi D, Asante KP, Newton S, Dosoo D, Amoako S, Adjei G, et al. Evaluation of the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa. PLoS One. 2015;10:e0125796.","journal-title":"PLoS One"},{"key":"531_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4269\/ajtmh.14-0100","volume":"91","author":"ME Fricken von","year":"2014","unstructured":"von Fricken ME, Weppelmann TA, Eaton WT, Masse R, de Rochars MV B, Okech BA. Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti. Am J Trop Med Hyg. 2014;91:77\u201380.","journal-title":"Am J Trop Med Hyg"},{"key":"531_CR25","doi-asserted-by":"publisher","first-page":"e116143","DOI":"10.1371\/journal.pone.0116143","volume":"9","author":"A Roca-Feltrer","year":"2014","unstructured":"Roca-Feltrer A, Khim N, Kim S, Chy S, Canier L, Kerleguer A, et al. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia. PLoS One. 2014;9:e116143.","journal-title":"PLoS One"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-015-0531-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-015-0531-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-015-0531-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T08:49:55Z","timestamp":1567414195000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-015-0531-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1186\/s12916-015-0531-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"296"}}